Advertisement
Hangzhou Tigermed Consulting Co., Ltd (HNGZY)
OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Follow
At close: 03:00PM EST
| Previous Close | 4.1400 |
| Open | 4.1400 |
| Bid | 2.0500 x 0 |
| Ask | 29.4500 x 0 |
| Day's Range | 4.1400 - 4.1400 |
| 52 Week Range | 4.1400 - 7.7800 |
| Volume | |
| Avg. Volume | 25 |
| Market Cap | 6.942B |
| Beta (5Y Monthly) | 0.85 |
| PE Ratio (TTM) | 27.60 |
| EPS (TTM) | 0.1500 |
| Earnings Date | Oct 29, 2024 |
| Forward Dividend & Yield | 0.08 (1.93%) |
| Ex-Dividend Date | Jun 11, 2024 |
| 1y Target Est | N/A |
PR NewswireTigermed Reports 2024 Interim Results
Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecycle of global biopharmaceutical and medical device products, announced its interim results for the first half of 2024, ended June 30, 2024 (the "Reporting Period").
ZacksVeeva Systems' (VEEV) Vault EDC to Boost Tigermed's Workflow
Veeva Systems' (VEEV) Vault EDC is likely to streamline key processes to accelerate study builds and make mid-study amendments with no downtime.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.